Canaccord raised the firm’s price target on iRhythm to $133 from $121 and keeps a Buy rating on the shares. The firm said they reported a strong topline Q4, but margins came in weaker than expected as Zio Monitor adoption drove near-term inefficiencies which are expected to be alleviated by 2H/24.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IRTC:
- iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results
- Irhythm Technologies (IRTC) Q4 Earnings Cheat Sheet
- iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
- SHAREHOLDER ALERT: Potential Recovery for iRhythm Technologies, Inc. (IRTC) Investors
- iRhythm reports closing of five-year debt facility
